Prescreening for clots also effective
Consortium aims to reduce life-threatening side effect of therapy
The future of VTE risk prediction in cancer
Prevention, early detection best strategy
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Tumor cells push the body toward a procoagulant state
Cleveland Clinic study of 3.7 million patients
Findings may help guide risk-adapted thromboprophylaxis
ASCO panels provide evidence-based recommendations
How aggressive should cancer screening efforts be?
Reducing time to treatment is good for patients and the healthcare system